HYBRID CONGRESS August 3-6 WPA 2022 EAN 2022 June 25-28 2022 Venue:Austria Center Vienna - ACV Bruno-Kreisky-Platz 1 1220 Vienna, Austria Congress website: Click here Once again, the Progress in Mind Resource Center is pleased to bring you highlights from this year's WPA Hybrid Congress. Migraine 20 Mar, 2024 Read Time: 3 mins Congress highlights If at first you don’t succeed, try another CGRP antibody for migraine prevention? If the first monoclonal antibody targeting calcitonin gene-related peptide fails to adequately... Depression, Bipolar 20 Feb, 2024 Read Time: 2 mins Congress highlights Are non-communicable diseases communicable? The role of the microbiome in mental illness Gut microbes influence brain function and behaviour through a variety of neural, endocrine and immune... Migraine 31 Jan, 2024 Read Time: 2 mins Congress highlights Preventive therapy reduces interictal burden of migraine The impact of migraine on a person’s life is multi-faceted; not only is there substantial functional... Mental Health 24 Jan, 2024 Read Time: 3 mins Congress highlights From diagnostic categories to underlying dysfunction Can one-size-fits-all diagnoses be replaced by a symptom-based approach which acknowledges the... Schizophrenia 15 Jan, 2024 Read Time: 3 mins Congress highlights Over pruning: synapses in the pathophysiology of schizophrenia Synaptic dysfunction is a key pathophysiological factor in schizophrenia. Various aspects of this... Migraine 10 Jan, 2024 Read Time: 2 mins Congress highlights Spotlight on CGRP sites of action in migraine Monoclonal antibodies targeting calcitonin gene-related peptide show good efficacy as preventive... Schizophrenia 02 Jan, 2024 Read Time: 3 mins Congress highlights Can deep brain stimulation treat schizophrenia? Widespread successful use of deep brain stimulation (DBS) to treat neurological conditions, such as... Schizophrenia 30 Oct, 2023 Efficacy and safety profiles are considerations when moving from acute to chronic treatment for schizophrenia At ECNP 2022, Professor Christoph Correll chatted about how both efficacy and safety profiles are... Depression, Anxiety 25 Oct, 2023 Assessing and addressing co-morbid depression and generalised anxiety disorder During ECNP 2022, Dr Iria Grande sat down and discussed how major depressive disorder (MDD) is... Schizophrenia 02 Oct, 2023 The importance of measuring patient satisfaction with treatment At ECNP 2022, Professor Leslie Citrome discussed the importance of measuring a patient’s satisfaction... Schizophrenia 06 Sep, 2023 Continued functional recovery in schizophrenia necessitates a long-term therapeutic alliance At ECNP 2022, Dr Charlotte Emborg sat down to chat about how barriers to functional recovery for... Schizophrenia 29 Aug, 2023 Taking the long-term view of schizophrenia treatment from first diagnosis Professor Christoph Correll discussed at ECNP 2022 the need for a holistic, long-term view of... Load More Most Popular Alzheimer's Disease 21 Nov, 2023 High Mobility Group Box 1 (HMGB1) in Vascular Dementia: Mechanism, Biomarker Potential, and Therapeutic Implication Alzheimer's Disease 27 Jul, 2023 Alzheimer's Disease: A Brief Pathophysiological Review & Update Schizophrenia 10 Aug, 2022 What should psychiatrists do to improve the physical health of patients with schizophrenia? Depression 27 Nov, 2023 The Interplay between Cancer and Depression Bipolar 12 Nov, 2021 Early versus Late - Does age of onset matter in bipolar disorder? Social Networks Other Conferences World Mental Health Day 2023 CONGRESS October 10 SIRS 2022 Congress ECNP 2021 HYBRID CONGRESS October 2-5
